Cargando…

Multiple Sclerosis and CCSVI: A Population-Based Case Control Study

BACKGROUND: Chronic cerebrospinal venous insufficiency (CCSVI) has been associated to multiple sclerosis (MS). OBJECTIVE: To evaluate the possible association between CCSVI and MS, using a population-based control design. METHODS: A random cohort of 148 incident MS patients were enrolled in the stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patti, Francesco, Nicoletti, Alessandra, Leone, Carmela, Messina, Silvia, D’Amico, Emanuele, Lo Fermo, Salvatore, Paradisi, Vincenza, Bruno, Elisa, Quattrocchi, Graziella, Veroux, Pierfrancesco, Di Pino, Luigi, Costanzo, Luca, Zappia, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411668/ https://www.ncbi.nlm.nih.gov/pubmed/22870210 http://dx.doi.org/10.1371/journal.pone.0041227

Ejemplares similares

Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS
por: Leone, Carmela, et al.
Publicado: (2013)

Toxoplasma gondii and multiple sclerosis: a population-based case–control study
por: Nicoletti, Alessandra, et al.
Publicado: (2020)

Negative prognostic impact of MRI spinal lesions in the early stages of relapsing–remitting multiple sclerosis
por: D’Amico, E, et al.
Publicado: (2016)

Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
por: D'Amico, Emanuele, et al.
Publicado: (2019)

Multiple Sclerosis in the Mount Etna Region: Possible Role of Volcanogenic Trace Elements
por: Nicoletti, Alessandra, et al.
Publicado: (2013)

Offspring Number Does Not Influence Reaching the Disability’s Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective
por: Toscano, Simona, et al.
Publicado: (2023)

Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis
por: Patti, Francesco, et al.
Publicado: (2011)

Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report
por: Patti, Francesco, et al.
Publicado: (2015)

The perfect crime? CCSVI not leaving a trace in MS
por: Mayer, Christoph A, et al.
Publicado: (2011)

Resilience, trust, and civic engagement in the post-CCSVI era
por: Benjaminy, Shelly, et al.
Publicado: (2018)

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
por: Comi, Giancarlo, et al.
Publicado: (2013)

“Media, politics and science policy: MS and evidence from the CCSVI Trenches”
por: Pullman, Daryl, et al.
Publicado: (2013)

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study
por: Driedger, S. Michelle, et al.
Publicado: (2017)

Self-Reported Diet and Health Outcomes of Participants of the CCSVI-Tracking Survey Study
por: Grace-Farfaglia, Patricia
Publicado: (2021)

Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers
por: Dolic, Kresimir, et al.
Publicado: (2011)

The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up
por: Van den Berg, Petronella J., et al.
Publicado: (2013)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Prevalence and Incidence of Epilepsy Associated with Convulsive Seizures in Rural Bolivia. A Global Campaign against Epilepsy Project
por: Bruno, Elisa, et al.
Publicado: (2015)

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
por: D’Amico, Emanuele, et al.
Publicado: (2018)

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022)

Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: Results of the PREMiSe pilot study
por: Zivadinov, Robert, et al.
Publicado: (2013)

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2019)

Seroprevalence of Toxocara Canis in the city of Catania, Italy
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis
por: Beggs, Clive B., et al.
Publicado: (2018)

Effects of Venous Angioplasty on Cerebral Lesions in Multiple Sclerosis: Expanded Analysis of the Brave Dreams Double-Blind, Sham-Controlled Randomized Trial
por: Zamboni, Paolo, et al.
Publicado: (2019)

Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
por: De Pasquale, Concetta, et al.
Publicado: (2014)

Correction to: Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID‑19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Toxocariasis and Epilepsy: Systematic Review and Meta-Analysis
por: Quattrocchi, Graziella, et al.
Publicado: (2012)

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
por: Zanghì, Aurora, et al.
Publicado: (2022)

Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
por: D'Amico, Emanuele, et al.
Publicado: (2021)

Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study
por: Zanghì, Aurora, et al.
Publicado: (2022)

Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
por: D'Amico, Emanuele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vtc8t6bj6tbf6h8oml01q2p4hg